Cosolv-CS

Cosolv-CS is a combination pharmaceutical formulation marketed by Emblazon Life Sciences (also referred to as Emblaze) for the symptomatic relief of dry cough and upper respiratory symptoms. It is a fixed-dose combination typically containing chlorpheniramine maleate and codeine phosphate. Chlorpheniramine maleate is a first-generation antihistamine that acts as a competitive antagonist at the H1 receptor, reducing allergic symptoms such as sneezing, itching, and rhinorrhea. Codeine phosphate is an opioid analgesic that functions as a centrally acting antitussive by suppressing the cough reflex through direct action on the cough center in the medulla oblongata. This combination is commonly used in the Indian pharmaceutical market for managing non-productive coughs associated with the common cold or allergies.

Brand names

Cosolv-CS

Other names

Cosolv-CS-Emblaze